Aquestive Therapeutics, Inc. (Aquestive) operates as a pharmaceutical company advancing medicines to bring meaningful improvement to patients’ lives through innovative science and delivery technologies.
The company is developing pharmaceutical produ…
Analysis
Middle-of-the-road
Aquestive Therapeutics, Inc. is a middle-of-the-road business: neither the economics nor the price stand out from the peer group.
Valuation data is not available for this company.
The trajectory is solid and the balance sheet is adequate. The company scores 7/20 on our value-creation score: creating some value.
Nothing is flagged here: no red or amber gates, no divergence between profits and cash. That is itself information: the numbers are straightforward. As always: this describes the company's numbers; it is not a recommendation.
360° rank · history
1007550250
Jan 202340
69
2023202420252026
All-time high
93
Jan 2024
All-time low
40
Jan 2023
Average rank
63
across all years
Detailed & Historical Ranks
Deep dive into 15 detailed ranks and 3 years of history.
Current202520242023
Price/Sales
32
15
33
62
Price/Earnings
78
42
42
42
Price/Book
88
93
89
92
Dividend Yield
1
1
1
1
Value (overall)
83
49
51
73
Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.